KYMR
Price
$20.77
Change
+$0.01 (+0.05%)
Updated
Dec 1, 6:59 PM EST
80 days until earnings call
RNA
Price
$8.10
Change
+$0.29 (+3.71%)
Updated
Dec 1, 6:59 PM EST
85 days until earnings call
Ad is loading...

KYMR vs RNA ᐉ Comparison: Which is Better to Invest?

Header iconKYMR vs RNA Comparison
Open Charts KYMR vs RNABanner chart's image
Kymera Therapeutics
Price$20.77
Change+$0.01 (+0.05%)
Volume$190.32K
CapitalizationN/A
Avidity Biosciences
Price$8.10
Change+$0.29 (+3.71%)
Volume$1.05M
CapitalizationN/A
View a ticker or compare two or three
KYMR vs RNA Comparison Chart

Loading...

Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
VS
KYMR vs. RNA commentary
Dec 04, 2023

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KYMR is a Hold and RNA is a Buy.

COMPARISON
Comparison
Dec 04, 2023
Stock price -- (KYMR: $20.77 vs. RNA: $8.10)
Brand notoriety: KYMR and RNA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: KYMR: 49% vs. RNA: 153%
Market capitalization -- KYMR: $1.09B vs. RNA: $456.46M
KYMR [@Biotechnology] is valued at $1.09B. RNA’s [@Biotechnology] market capitalization is $456.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $464.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.29B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

KYMR’s FA Score shows that 0 FA rating(s) are green whileRNA’s FA Score has 0 green FA rating(s).

  • KYMR’s FA Score: 0 green, 5 red.
  • RNA’s FA Score: 0 green, 5 red.
According to our system of comparison, RNA is a better buy in the long-term than KYMR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

KYMR’s TA Score shows that 5 TA indicator(s) are bullish while RNA’s TA Score has 6 bullish TA indicator(s).

  • KYMR’s TA Score: 5 bullish, 4 bearish.
  • RNA’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, RNA is a better buy in the short-term than KYMR.

Price Growth

KYMR (@Biotechnology) experienced а +4.11% price change this week, while RNA (@Biotechnology) price change was +29.39% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +3.15%. For the same industry, the average monthly price growth was +30.64%, and the average quarterly price growth was +27.15%.

Reported Earning Dates

KYMR is expected to report earnings on Feb 22, 2024.

RNA is expected to report earnings on Feb 27, 2024.

Industries' Descriptions

@Biotechnology (+3.15% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
A.I.dvisor published
a Summary for KYMR with price predictions.
OPEN
A.I.dvisor published
a Summary for RNA with price predictions.
OPEN
FUNDAMENTALS
Fundamentals
KYMR($1.09B) has a higher market cap than RNA($456M). KYMR YTD gains are higher at: -16.787 vs. RNA (-63.497). KYMR has higher annual earnings (EBITDA): -163.76M vs. RNA (-215.3M). RNA has more cash in the bank: 543M vs. KYMR (358M). RNA has less debt than KYMR: RNA (10.6M) vs KYMR (80.8M). KYMR has higher revenues than RNA: KYMR (46.8M) vs RNA (10.1M).
KYMRRNAKYMR / RNA
Capitalization1.09B456M239%
EBITDA-163.76M-215.3M76%
Gain YTD-16.787-63.49726%
P/E Ratio74.07N/A-
Revenue46.8M10.1M463%
Total Cash358M543M66%
Total Debt80.8M10.6M762%
TECHNICAL ANALYSIS
Technical Analysis
KYMRRNA
RSI
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
88%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
76%
MACD
ODDS (%)
N/A
Bullish Trend 4 days ago
87%
TrendWeek
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
83%
Bullish Trend 4 days ago
85%
Advances
ODDS (%)
Bullish Trend 4 days ago
86%
Bullish Trend 6 days ago
82%
Declines
ODDS (%)
Bearish Trend 26 days ago
90%
Bearish Trend 14 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
83%
Aroon
ODDS (%)
Bullish Trend 4 days ago
82%
Bullish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PSLCX10.080.29
+2.96%
Putnam Small Cap Value C
RSEFX16.760.27
+1.64%
Royce Small-Cap Special Equity Svc
VEVYX46.900.75
+1.63%
Victory Sycamore Established Value Y
BGITX12.160.08
+0.69%
Baillie Gifford International Alpha 2
SBHEX8.470.04
+0.47%
Segall Bryant & Hamill Em Mkts Retl

KYMR and

Correlation & Price change

A.I.dvisor indicates that over the last year, KYMR has been loosely correlated with EDIT. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if KYMR jumps, then EDIT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To KYMR
1D Price
Change %
KYMR100%
+0.05%
EDIT - KYMR
52%
Loosely correlated
+2.28%
DNLI - KYMR
51%
Loosely correlated
+2.43%
MDGL - KYMR
48%
Loosely correlated
+4.83%
BEAM - KYMR
48%
Loosely correlated
+5.31%
INBX - KYMR
48%
Loosely correlated
+7.80%
More